Advertisement

Topics

Vical Incorporated Company Profile

23:23 EDT 20th October 2017 | BioPortfolio

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.


News Articles [20 Associated News Articles listed on BioPortfolio]

Vical Incorporated (VICL) Cut to Strong Sell at ValuEngine

A number of other equities research analysts have also issued reports on the stock. HC Wainwright set a $9.00 target price on shares of Vical and gave the company a "buy" rating in a research note on ...

Vical Announces Completion Of The Phase III ASP0113 CMV Vaccine Trial

- Astellas expects topline results in 1Q2018 SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the last patient completed their final assessment duri...

Investor Network Invites You to the Vical Second Quarter 2017 Earnings Webcast Live on Tuesday, August 8, 2017

SAN DIEGO, CA / ACCESSWIRE / August 8, 2017 / Vical Incorporated (NASDAQ: VICL) will host a live webcast to discuss the results of the second quarter 2017, to be held Tuesday, August 8, 2017, 2017 ...

Vical Incorporated Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Vical Incorporated Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Vical Incorporated Mergers Acquisitions MA, Partnerships Alliances and Investments repo...

Vical completes enrollment in Phase II of HSV-2 vaccine

Vical to Present at IDWeek and the 8th Trends in Medical Mycology Conferences

SAN DIEGO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company will present a poster on its antifungal VL-2397 development program at the Infectio...

Vical Announces Completion of the Phase 3 ASP0113 CMV Vaccine Trial

SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the last patient completed their final assessment during the one year follow-up period in the mu...

Vical to Provide Company Update at BIO Investor Forum Conference

SAN DIEGO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 1...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [38 Associated Companies listed on BioPortfolio]

Vical

Vical is developing gene-based pharmaceutical products for human therapy. Vical's patented naked DNA gene delivery technology and proprietary lipids are designed to deliver selected genes into some ce...

Vical Incorporated

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applica...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "Vical Incorporated" on BioPortfolio

We have published hundreds of Vical Incorporated news stories on BioPortfolio along with dozens of Vical Incorporated Clinical Trials and PubMed Articles about Vical Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vical Incorporated Companies in our database. You can also find out about relevant Vical Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record